AI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.

AI-enabled clinical trial technology enables faster processing of large data volumes, thereby enhancing workflows, easing the burden on busy trial teams, and protecting patients.

To better accommodate growing clinical data volume and decentralized trials, many organizations are activating AI-enabled trial tools to enhance workflows and ensure real time data review.

Are you considering integrating AI and ML into your workflow? These six considerations will help you plan out an effective trial.

Artificial intelligence is reshaping regulatory medical writing by accelerating document development while maintaining compliance and scientific rigor, creating faster, regulator-ready submissions without compromising quality.

Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.

In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.

This dynamic, system-agnostic approach to modernizing clinical trial monitoring supports targeted oversight, as well as sampling at the subject, visit, and form levels.

An advanced AI-powered platform designed to revolutionize clinical trial planning and execution leverages deep learning and proprietary performance data to deliver highly accurate, real-time forecasts.

Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.

Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.